Search Results
UPDATED: Novartis falls short in controversial IPR process as board nixes Gilenya patent
for Affordable Drugs. Bass' group has filed multiple challenges to what it calls "low-quality" ...
InnFocus raises $33M to back pivotal trial for glaucoma microshunt
micro stent player Glaukos files to raise up to $86M in an IPO Startup Transcend to submit PMA in second ...
WHO chief Margaret Chan vows to boost preparedness for disease outbreaks
vaccines to farmers in Africa. The event was sponsored by the Bill & Melinda Gates Foundation, which ...
Baxter makes nice with activist investor Third Point, offers board seats
Point SEC filing Related Articles: Activist investor Third Point takes on Baxter with 10% stake, wants ...
New Hampshire AG launches investigation into opioid marketing
have taken drugmakers to task over opioid marketing. Last year, California filed suit against Actavis ...
Advaxis targets HER2 cancers with first-in-human vaccine trial
'encouraging' PhII cervical cancer vaccine data Advaxis nets $23M in financing for cancer vaccine development ...
Novavax's RSV jab protects infants in PhII, nets $89M Gates Foundation grant
positive data for the Phase I trial of its investigational Ebola vaccine and for the Phase II trial of its ...
FierceBiotech's 2015 Fierce 15
8 companies that have filed or completed an IPO. Two more have clearly completed crossover rounds that put ...
Industry and academia join sides to test DART therapy in HIV-infected cells
of the Duke Human Vaccine Institute, in a release. The results were published in the Journal of Clinical ...
India's Dr. Reddy's strategy on biosimilars now refined for big punches
at a quarter of the cost of the original. Lupin has said it plans for a 2017 filing in Japan for etanercept, ...
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- next ›
- last »
